Science Explorer Back to mapMap
Discussion
Topic · Surgery

Vascular Malformations and Hemangiomas

Vascular Malformations and Hemangiomas is a research topic within Surgery. Science Explorer counts 25k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the classification, diagnosis, and treatment of vascular anomalies, including hemangiomas, vascular malformations, and lymphatic malformations. It covers topics such as the use of propranolol and sirolimus in treating infantile hemangiomas, the genetic mutations associated with various syndromes, and the management of conditions like Sturge-Weber syndrome, PHACE syndrome, and Klippel-Trenaunay syndrome.

  • Hemangiomas
  • Vascular Malformations
  • Propranolol
  • PIK3CA Mutations
  • Lymphatic Malformations
  • Sturge-Weber Syndrome
  • RASA1 Mutations
  • Sirolimus
  • PHACE Syndrome
  • Klippel-Trenaunay Syndrome
Research works
25k
fractional, since 1950
In the world top 10%
2.5k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+9%
the tick is no change
Largest producer
United States
29% of the 10 largest, 2022-now
Vascular Malformations and Hemangiomas

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Vascular Malformations and Hemangiomas research?

By volume, the United States and China publish the most (1k and 685 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1k works
  2. 2 China 685 works
  3. 3 India 581 works
  4. 4 Japan 335 works
  5. 5 Brazil 257 works
  6. 6 Spain 151 works
  7. 7 Italy 150 works
  8. 8 United Kingdom 129 works
  9. 9 France 126 works
  10. 10 Türkiye 123 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.9%China: 19.2%India: 16.3%Japan: 9.4%6 others listed: 26.3%29%largest
United States1,029 · 28.9%China685 · 19.2%India581 · 16.3%Japan335 · 9.4%6 others listed937 · 26.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Vascular Malformations and Hemangiomas research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Vascular Malformations and Hemangiomas research, followed by Shanghai Jiao Tong University and Harvard University.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 65 works
  2. 2 Shanghai Jiao Tong UniversityChina 52 works
  3. 3 Harvard UniversityUnited States 49 works
  4. 4 Sichuan UniversityChina 45 works
  5. 5 Capital Medical UniversityChina 31 works
  6. 6 Mayo ClinicUnited States 31 works
  7. 7 Johns Hopkins UniversityUnited States 27 works
  8. 8 Baylor College of MedicineUnited States 19 works
  9. 9 Universidade de São PauloBrazil 18 works
  10. 10 Children's Hospital of PhiladelphiaUnited States 18 works

Who are the leading researchers in Vascular Malformations and Hemangiomas?

The most-cited researchers publishing on Vascular Malformations and Hemangiomas include Giuseppe Remuzzi, Alberto Mantovani and Kai You Wang.

  1. 1 Giuseppe Remuzzi Italy 328k citations
  2. 2 Alberto Mantovani Italy 224k citations
  3. 3 Kai You Wang China 224k citations
  4. 4 Dirk Schadendorf Germany 222k citations
  5. 5 Norberto Perico Italy 220k citations
  6. 6 Alberto Arduan Ortiz Spain 219k citations
  7. 7 Clifford R. Jack United States 218k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Vascular Malformations and Hemangiomas?

The most cited paper in Vascular Malformations and Hemangiomas is "Lymphangiogenesis: Molecular Mechanisms and Future Promise" (Tuomas Tammela, Kari K. Alitalo, 2010), with 1,469 citations. Next come "Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies" (1,425) and "Recurrent BRAF mutations in Langerhans cell histiocytosis" (1,255).

Most cited papers
#PaperReleasedCitations
1 Lymphangiogenesis: Molecular Mechanisms and Future Promise Tuomas Tammela, Kari K. Alitalo · Cell Open access Feb 2010 1,469
2 Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies Michel Wassef, Francine Blei, Denise M. Adams et al. · PEDIATRICS 10 Jun 2015 1,425
3 Recurrent BRAF mutations in Langerhans cell histiocytosis Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara A. Degar et al. · Blood Open access 2 Jun 2010 1,255
4 Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ Matthew D. Shirley, Hao Tang, Carol J. Gallione et al. · New England Journal of Medicine Open access 8 May 2013 1,116
5 Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries Silvana Breiteneder-Geleff, Afschin Soleiman, Heinrich Kowalski et al. · American Journal Of Pathology Open access Feb 1999 1,099
All 100 most cited papers, with filters and sorting

Where is Vascular Malformations and Hemangiomas research done?

The largest centres of Vascular Malformations and Hemangiomas research in 2022-now are Beijing (China), Shanghai (China), Tokyo (Japan) and New Delhi (India).

Largest cities, 2022-now

  1. 1 BeijingChina 101 works
  2. 2 ShanghaiChina 80 works
  3. 3 TokyoJapan 74 works
  4. 4 New DelhiIndia 71 works
  5. 5 São PauloBrazil 63 works
  6. 6 ChengduChina 57 works
  7. 7 LondonUnited Kingdom 50 works
  8. 8 BostonUnited States 46 works
  9. 9 New YorkUnited States 46 works
  10. 10 ParisFrance 44 works
See Vascular Malformations and Hemangiomas on the map

Where is the best place to study Vascular Malformations and Hemangiomas?

Among universities, judged by research, Harvard University, Johns Hopkins University and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 22.29%fractional works in this field (log) →share of work in the world top 10% →University of Cincin…Johns Hopkins Univer…Sichuan UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 71.522.6%3.5×49 -7.8%
2Johns Hopkins UniversityUnited States 70.529.8%3.9×27 +31.0%
3Sichuan UniversityChina 66.623.9%4.5×45 +46.5%
4University of CincinnatiUnited States 64.140.4%5.8×15 -1.6%
5Shanghai Jiao Tong UniversityChina 60.518.6%4.1×52 +0.8%
6All India Institute of Medical SciencesIndia 53.24.4%13.4×65 +76.8%
7Capital Medical UniversityChina 51.419.5%6.6×31 -1.6%
8Baylor College of MedicineUnited States 49.217.4%8.7×19 -1.5%
9University of PennsylvaniaUnited States 48.524.0%3.1×15 +8.5%
10University of TorontoCanada 43.422.3%1.7×15 -17.6%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Vascular Malformations and Hemangiomas, country by country

Is Vascular Malformations and Hemangiomas research growing?

Output in 2022-2025 was 9% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Vascular Malformations and Hemangiomas.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vascular Malformations and Hemangiomas as a percentage of every work published that year, 0.021% in 2024.

still counting0.010%0.020%0.030%Vascular Malformations and Hemangiomas0.021% in 202519801990200020102020

Fractional works of Vascular Malformations and Hemangiomas over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Vascular Malformations and Hemangiomas10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Vascular Malformations and Hemangiomas. Posts are plain text and can be reported.